# RTSN (Retension Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> Retension Pharmaceuticals, Inc. reported $14.15M in total assets through September 30, 2026 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/RTSN
- Markdown: https://convexityos.com/fundamentals/RTSN.md
- SEC CIK: 0002002988
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:53 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002002988&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2026 | -- | Sep 30, 2026 |
| Operating Income | FY 2026 | -- | Operating profit |
| Net Income | FY 2026 | -- | GAAP bottom line |
| Diluted EPS | FY 2026 | -- | Split-adjusted |
| Free Cash Flow | FY 2026 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $9.19M | Total debt: -- |

## Income Statement

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $5.02M | -- | -- | $1.37M | -- | -- |
| Total Operating Expenses | $6.01M | -- | -- | $1.66M | -- | -- |
| **Operating Income** | -$6.01M | -- | -- | -$1.66M | -- | -- |
| Interest Income | $89K | -- | -- | $189K | -- | -- |
| **Net Income** | -$5.92M | -$4.14M | -$3.38M | -$1.48M | -$1.23M | -$656K |
| Basic EPS | -$7.33 | -- | -- | -$1.83 | -- | -- |
| **Diluted EPS** | -$7.33 | -- | -- | -$1.83 | -- | -- |
| Basic Shares Outstanding | 807.9K | -- | -- | 805.2K | -- | -- |
| Diluted Shares Outstanding | 807.9K | -- | -- | 805.2K | -- | -- |

## Balance Sheet

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Dec 2025 |
| --- | --- | --- |
| Cash & Cash Equivalents | $9.19M | $18.90M |
| **Cash & Short-Term Investments** | $9.19M | $18.90M |
| **Total Current Assets** | $14.15M | $21.45M |
| **Total Non-Current Assets** | $0 | $0 |
| **Total Assets** | $14.15M | $21.45M |
| Accounts Payable | $3.89M | $776K |
| **Total Current Liabilities** | $6.66M | $912K |
| **Total Non-Current Liabilities** | $0 | $0 |
| **Total Liabilities** | $6.66M | $912K |
| Common Stock | $81 | $81 |
| Retained Earnings | -$21.76M | -$8.32M |
| **Total Stockholders' Equity** | -$20.66M | -$7.78M |
| Total Equity | -$20.66M | -$7.78M |

## Cash Flow Statement

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$5.92M | -$4.14M | -$3.38M | -$1.48M | -$1.23M | -$656K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- |
| Current Ratio | 2.12x | -- | -- | -- | -- | -- |
| Quick Ratio | 1.38x | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
